Where & When

Saturday, September 27, 2025
Detroit Marriott Troy
200 W Big Beaver Rd.
Troy, MI 48084

Breakfast and registration opens 7:00 a.m.

Download the flyer

Registration

Don’t Delay! Registration Deadline is Thursday, September 25.

Pre-registration is encouraged.

Register Now

Program Director

Hirva Mamdani, M.D.

Accreditation

This activity has been approved for up to 5.50 AMA PRA Category 1 Credit™

Provided by Wayne State University School of Medicine and Karmanos Cancer Institute.

Agenda

7 - 8 a.m.
Registration & Breakfast

8:00 - 8:10 a.m.
Welcoming Remarks
Hirva Mamdani, M.D., Program Director

8:10 - 8:30 a.m.
Lung Cancer Screening in 2025
Amina Pervaiz, M.D.
Karmanos Cancer Institute, Wayne State University

8:30 - 8:55 a.m.
Perioperative Immunotherapy for Resectable NSCLC
Guest Speaker: Ryan Gentzler, M.D.
University of Virginia

8:55 - 9:20 a.m.
Perioperative Targeted Therapy for Resectable NSCLC
Guest Speaker: Antoinette Wozniak, M.D.
Lung Cancer Research Foundation

9:20 - 9:45 a.m.
Locally Advanced Unresectable NSCLC: Current Approach and Future Directions
Dipesh Uprety, M.D. FACP
Karmanos Cancer Institute/Wayne State University

9:45 - 10:15
Case Presentations and Panel Discussion
Presenter: Khalil Choucair, M.D., MSc
Karmanos Cancer Institute, Wayne State University
Moderator: Hirva Mamdani, M.D.

10:15 - 10:35 a.m.
Break

10:35 - 11:00 a.m.
Small Cell Lung Cancer: Treatment Breakthroughs and Challenges
Guest Speaker: Meera Patel, M.D.
Baylor College of Medicine

11:00 - 11:25 a.m.
Treatment of Advanced NSCLC harboring EGFR Mutation
Guest Speaker: Julia Rotow, M.D.
Dana Farber Cancer Institute

11:25 - 11:50 a.m.
Treatment of Advanced NSCLC without Actionable Genomic Alterations
Guest Speaker: Saiama Waqar, M.D. MSCI
Washington University School of Medicine

11:50 a.m. - 12:30 p.m.
Lunch

12:30 - 12:55 p.m.
Updates in the Treatment of Advanced NSCLC Harboring ALK, ROS-1, and MET Alterations
Khalil Choucair, M.D., MSc
Karmanos Cancer Institute, Wayne State University

12:55 - 1:20 p.m.
Updates in the Treatment of Advanced NSCLC Harboring KRAS and HER-2 Alterations
Tarik Hadid, M.D.
Karmanos Cancer Institute, Wayne State University

1:20 - 1:40 p.m.
Shared Decision Making in Oncology
Morhaf Al Achkar, M.D.
Karmanos Cancer Institute, Wayne State University

1:40 - 2:10 p.m.
Case Presentations and Panel Discussion
Presenter: Khalil Choucair, M.D., MSc
Karmanos Cancer Institute, Wayne State University
Moderator: Hirva Mamdani, M.D.

2:10 - 2:15 p.m.
Closing Remarks
Hirva Mamdani, M.D.

More Information

For any additional questions, please contact Pamela Sydorchuk, symposium coordinator, at symposium@karmanos.org or call 313-576-8746.

The Latest From Karmanos Cancer Institute

News

KSP, McLaren’s Specialty Pharmacy, Recognized as a Leader in Performance Measurement for Third Consecutive Year

The Utilization Review Accreditation Commission (URAC) has again awarded KSP , McLaren’s Specialty Pharmacy, as a 2024 Specialty Pharmacy Pioneer ...

Read More

Tickets on Sale Now, Karmanos Cancer Institute’s 3rd Annual Classic Cars for the Cure

The  Barbara Ann Karmanos Cancer Institute is gearing up for the third annual Classic Cars for the Cure on Saturday, Sept. 20. Tickets are no...

Read More

Is It Time to Schedule Your Cancer Screenings? Here’s What You Need to Know

If you’re at the age where cancer screenings are recommended—or even overdue—consider this your reminder to get them on the calendar. Just like yo...

Read More
News

105.9 KISS FM | Getting a Second Opinion at Karmanos

Listen Now

WJR | Karmanos Cancer Institute Continues Its Community Education Series

Listen Now

WXYT 97.1 The Ticket | ‘Get a Mammogram’

Listen Now